Europe Biosimulation Market Size, Share & Trends Analysis Report By Product, By Pricing Model, By End Use, By Application, By Deployment Model (Cloud-based, On-premises, and Hybrid Model), By Therapeutic Area, By Country and Growth Forecast, 2024

List of Tables

The Europe Biosimulation Market would witness market growth of 16.3% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Biosimulation Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $644.3 million by 2031. The UK market is exhibiting a CAGR of 15.3% during (2024 - 2031). Additionally, The France market would experience a CAGR of 17.1% during (2024 - 2031).

One of the primary drivers of this market is the rapid advancement in computational power and technologies such as artificial intelligence (AI) and machine learning (ML). These technologies have enhanced the accuracy and scalability of these models, enabling researchers to simulate complex biological interactions that were previously beyond reach.

Initiatives such as the FDA's Model-Informed Drug Development (MIDD) program have encouraged the adoption of this for regulatory submissions, allowing pharmaceutical companies to expedite approvals and bring innovative therapies to market faster. This regulatory endorsement has also led to integrating this into clinical trial designs, helping researchers identify optimal patient cohorts and minimize risks.

Switzerland and Italy further contribute to the European market, focusing on biotechnology and healthcare digitization. In Switzerland, companies like Novartis and Roche have employed this for cardiovascular drugs and Alzheimer's treatments, supported by funding from the Swiss Innovation Agency (Innosuisse). Under the National Recovery and Resilience Plan (NRRP), Italy has promoted this for respiratory disorder therapies, with companies like Chiesi Group and academic institutions exploring its potential in rare disease research. These efforts highlight Europe's collaborative and innovative landscape, where they drives advancements across diverse therapeutic areas.

Based on Product, the market is segmented into Software (Molecular Modeling & Simulation Software, Clinical Trial Design Software, PK/PD Modeling and Simulation Software, Pbpk Modeling and Simulation Software, Toxicity Prediction Software, and Other Software Type) and Services (Contract Services, Consulting, and Other Services Type). Based on Pricing Model, the market is segmented into License-based Model, Subscription-based Model, Service-based Model, and Pay Per Use Model. Based on End Use, the market is segmented into Life Sciences Companies, Academic Research Institutions, and Other End Use. Based on Application, the market is segmented into Drug Discovery & Development, Disease Modeling, and Other Application. Based on Deployment Model, the market is segmented into Cloud-based, On-premises, and Hybrid Model. Based on Therapeutic Area, the market is segmented into Oncology, Cardiovascular Disease, Infectious Disease, Neurological Disorders, and Other Therapeutic Area. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

Certara, Inc.
Dassault Systemes SE
Advanced Chemistry Development, Inc.
Genedata AG (Danaher Corporation)
Instem Group of Companies
Chemical Computing Group ULC
Simulations Plus, Inc.
Schrodinger, Inc.
PPD, Inc. (Thermo Fisher Scientific, Inc.)
Physiomics Plc

Europe Biosimulation Market Report Segmentation

By Product

Software
- Molecular Modeling & Simulation Software
- Clinical Trial Design Software
- PK/PD Modeling and Simulation Software
- Pbpk Modeling and Simulation Software
- Toxicity Prediction Software
- Other Software Type
Services
- Contract Services
- Consulting
- Other Services Type

By Pricing Model

License-based Model
Subscription-based Model
Service-based Model
Pay Per Use Model

By End Use

Life Sciences Companies
Academic Research Institutions
Other End Use

By Application

Drug Discovery & Development
Disease Modeling
Other Application

By Deployment Model

Cloud-based
On-premises
Hybrid Model

By Therapeutic Area

Oncology
Cardiovascular Disease
Infectious Disease
Neurological Disorders
Other Therapeutic Area

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Biosimulation Market, by Product
- 1.4.2 Europe Biosimulation Market, by Pricing Model
- 1.4.3 Europe Biosimulation Market, by End Use
- 1.4.4 Europe Biosimulation Market, by Application
- 1.4.5 Europe Biosimulation Market, by Deployment Model
- 1.4.6 Europe Biosimulation Market, by Therapeutic Area
- 1.4.7 Europe Biosimulation Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

4.1 Market Share Analysis, 2023
4.2 Strategies Deployed in Biosimulation Market
4.3 Porter Five Forces Analysis

Chapter 5. Europe Biosimulation Market by Product

5.1 Europe Software Market by Country
5.2 Europe Biosimulation Market by Software Type
- 5.2.1 Europe Molecular Modeling & Simulation Software Market by Country
- 5.2.2 Europe Clinical Trial Design Software Market by Country
- 5.2.3 Europe PK/PD Modeling and Simulation Software Market by Country
- 5.2.4 Europe Pbpk Modeling and Simulation Software Market by Country
- 5.2.5 Europe Toxicity Prediction Software Market by Country
- 5.2.6 Europe Other Software Type Market by Country
5.3 Europe Services Market by Country
5.4 Europe Biosimulation Market by Services Type
- 5.4.1 Europe Contract Services Market by Country
- 5.4.2 Europe Consulting Market by Country
- 5.4.3 Europe Other Services Type Market by Country

Chapter 6. Europe Biosimulation Market by Pricing Model

6.1 Europe License-based Model Market by Country
6.2 Europe Subscription-based Model Market by Country
6.3 Europe Service-based Model Market by Country
6.4 Europe Pay Per Use Model Market by Country

Chapter 7. Europe Biosimulation Market by End Use

7.1 Europe Life Sciences Companies Market by Country
7.2 Europe Academic Research Institutions Market by Country
7.3 Europe Other End Use Market by Country

Chapter 8. Europe Biosimulation Market by Application

8.1 Europe Drug Discovery & Development Market by Country
8.2 Europe Disease Modeling Market by Country
8.3 Europe Other Application Market by Country

Chapter 9. Europe Biosimulation Market by Deployment Model

9.1 Europe Cloud-based Market by Country
9.2 Europe On-premises Market by Country
9.3 Europe Hybrid Model Market by Country

Chapter 10. Europe Biosimulation Market by Therapeutic Area

10.1 Europe Oncology Market by Country
10.2 Europe Cardiovascular Disease Market by Country
10.3 Europe Infectious Disease Market by Country
10.4 Europe Neurological Disorders Market by Country
10.5 Europe Other Therapeutic Area Market by Country

Chapter 11. Europe Biosimulation Market by Country

11.1 Germany Biosimulation Market
- 11.1.1 Germany Biosimulation Market by Product
  - 11.1.1.1 Germany Biosimulation Market by Software Type
  - 11.1.1.2 Germany Biosimulation Market by Services Type
- 11.1.2 Germany Biosimulation Market by Pricing Model
- 11.1.3 Germany Biosimulation Market by End Use
- 11.1.4 Germany Biosimulation Market by Application
- 11.1.5 Germany Biosimulation Market by Deployment Model
- 11.1.6 Germany Biosimulation Market by Therapeutic Area
11.2 UK Biosimulation Market
- 11.2.1 UK Biosimulation Market by Product
  - 11.2.1.1 UK Biosimulation Market by Software Type
  - 11.2.1.2 UK Biosimulation Market by Services Type
- 11.2.2 UK Biosimulation Market by Pricing Model
- 11.2.3 UK Biosimulation Market by End Use
- 11.2.4 UK Biosimulation Market by Application
- 11.2.5 UK Biosimulation Market by Deployment Model
- 11.2.6 UK Biosimulation Market by Therapeutic Area
11.3 France Biosimulation Market
- 11.3.1 France Biosimulation Market by Product
  - 11.3.1.1 France Biosimulation Market by Software Type
  - 11.3.1.2 France Biosimulation Market by Services Type
- 11.3.2 France Biosimulation Market by Pricing Model
- 11.3.3 France Biosimulation Market by End Use
- 11.3.4 France Biosimulation Market by Application
- 11.3.5 France Biosimulation Market by Deployment Model
- 11.3.6 France Biosimulation Market by Therapeutic Area
11.4 Russia Biosimulation Market
- 11.4.1 Russia Biosimulation Market by Product
  - 11.4.1.1 Russia Biosimulation Market by Software Type
  - 11.4.1.2 Russia Biosimulation Market by Services Type
- 11.4.2 Russia Biosimulation Market by Pricing Model
- 11.4.3 Russia Biosimulation Market by End Use
- 11.4.4 Russia Biosimulation Market by Application
- 11.4.5 Russia Biosimulation Market by Deployment Model
- 11.4.6 Russia Biosimulation Market by Therapeutic Area
11.5 Spain Biosimulation Market
- 11.5.1 Spain Biosimulation Market by Product
  - 11.5.1.1 Spain Biosimulation Market by Software Type
  - 11.5.1.2 Spain Biosimulation Market by Services Type
- 11.5.2 Spain Biosimulation Market by Pricing Model
- 11.5.3 Spain Biosimulation Market by End Use
- 11.5.4 Spain Biosimulation Market by Application
- 11.5.5 Spain Biosimulation Market by Deployment Model
- 11.5.6 Spain Biosimulation Market by Therapeutic Area
11.6 Italy Biosimulation Market
- 11.6.1 Italy Biosimulation Market by Product
  - 11.6.1.1 Italy Biosimulation Market by Software Type
  - 11.6.1.2 Italy Biosimulation Market by Services Type
- 11.6.2 Italy Biosimulation Market by Pricing Model
- 11.6.3 Italy Biosimulation Market by End Use
- 11.6.4 Italy Biosimulation Market by Application
- 11.6.5 Italy Biosimulation Market by Deployment Model
- 11.6.6 Italy Biosimulation Market by Therapeutic Area
11.7 Rest of Europe Biosimulation Market
- 11.7.1 Rest of Europe Biosimulation Market by Product
  - 11.7.1.1 Rest of Europe Biosimulation Market by Software Type
  - 11.7.1.2 Rest of Europe Biosimulation Market by Services Type
- 11.7.2 Rest of Europe Biosimulation Market by Pricing Model
- 11.7.3 Rest of Europe Biosimulation Market by End Use
- 11.7.4 Rest of Europe Biosimulation Market by Application
- 11.7.5 Rest of Europe Biosimulation Market by Deployment Model
- 11.7.6 Rest of Europe Biosimulation Market by Therapeutic Area

Chapter 12. Company Profiles

12.1 Certara, Inc.
- 12.1.1 Company Overview
- 12.1.2 Financial Analysis
- 12.1.3 Regional Analysis
- 12.1.4 Research & Development Expenses
- 12.1.5 Recent strategies and developments:
  - 12.1.5.1 Product Launches and Product Expansions:
  - 12.1.5.2 Acquisition and Mergers:
- 12.1.6 SWOT Analysis
12.2 Dassault Systemes SE
- 12.2.1 Company Overview
- 12.2.2 Financial Analysis
- 12.2.3 Regional Analysis
- 12.2.4 Research & Development Expense
- 12.2.5 SWOT Analysis
12.3 Advanced Chemistry Development, Inc.
- 12.3.1 Company Overview
12.4 Genedata AG (Danaher Corporation)
- 12.4.1 Company Overview
- 12.4.2 Financial Analysis
- 12.4.3 Segmental and Regional Analysis
- 12.4.4 Research & Development Expense
- 12.4.5 Recent strategies and developments:
  - 12.4.5.1 Partnerships, Collaborations, and Agreements:
12.5 Instem Group of Companies
- 12.5.1 Company Overview
12.6 Chemical Computing Group ULC
- 12.6.1 Company Overview
12.7 Simulations Plus, Inc.
- 12.7.1 Company Overview
- 12.7.2 Financial Analysis
- 12.7.3 Segmental and Regional Analysis
- 12.7.4 Research & Development Expenses
- 12.7.5 Recent strategies and developments:
  - 12.7.5.1 Partnerships, Collaborations, and Agreements:
  - 12.7.5.2 Product Launches and Product Expansions:
  - 12.7.5.3 Acquisition and Mergers:
- 12.7.6 SWOT Analysis
12.8 Schrodinger, Inc.
- 12.8.1 Company Overview
- 12.8.2 Financial Analysis
- 12.8.3 Segmental and Regional Analysis
- 12.8.4 Research & Development Expenses
12.9 PPD, Inc. (Thermo Fisher Scientific, Inc.)
- 12.9.1 Company Overview
- 12.9.2 Financial Analysis
- 12.9.3 Segmental and Regional Analysis
- 12.9.4 Research & Development Expenses
12.10. Physiomics Plc
- 12.10.1 Company Overview
- 12.10.2 Financial Analysis

LIST OF TABLES

TABLE 1 Europe Biosimulation Market, 2020 - 2023, USD Million
TABLE 2 Europe Biosimulation Market, 2024 - 2031, USD Million
TABLE 3 Europe Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 4 Europe Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 5 Europe Software Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Software Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 8 Europe Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 9 Europe Molecular Modeling & Simulation Software Market by Country, 2020 - 2023, USD Million
TABLE 10 Europe Molecular Modeling & Simulation Software Market by Country, 2024 - 2031, USD Million
TABLE 11 Europe Clinical Trial Design Software Market by Country, 2020 - 2023, USD Million
TABLE 12 Europe Clinical Trial Design Software Market by Country, 2024 - 2031, USD Million
TABLE 13 Europe PK/PD Modeling and Simulation Software Market by Country, 2020 - 2023, USD Million
TABLE 14 Europe PK/PD Modeling and Simulation Software Market by Country, 2024 - 2031, USD Million
TABLE 15 Europe Pbpk Modeling and Simulation Software Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Pbpk Modeling and Simulation Software Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Toxicity Prediction Software Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Toxicity Prediction Software Market by Country, 2024 - 2031, USD Million
TABLE 19 Europe Other Software Type Market by Country, 2020 - 2023, USD Million
TABLE 20 Europe Other Software Type Market by Country, 2024 - 2031, USD Million
TABLE 21 Europe Services Market by Country, 2020 - 2023, USD Million
TABLE 22 Europe Services Market by Country, 2024 - 2031, USD Million
TABLE 23 Europe Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 24 Europe Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 25 Europe Contract Services Market by Country, 2020 - 2023, USD Million
TABLE 26 Europe Contract Services Market by Country, 2024 - 2031, USD Million
TABLE 27 Europe Consulting Market by Country, 2020 - 2023, USD Million
TABLE 28 Europe Consulting Market by Country, 2024 - 2031, USD Million
TABLE 29 Europe Other Services Type Market by Country, 2020 - 2023, USD Million
TABLE 30 Europe Other Services Type Market by Country, 2024 - 2031, USD Million
TABLE 31 Europe Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 32 Europe Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 33 Europe License-based Model Market by Country, 2020 - 2023, USD Million
TABLE 34 Europe License-based Model Market by Country, 2024 - 2031, USD Million
TABLE 35 Europe Subscription-based Model Market by Country, 2020 - 2023, USD Million
TABLE 36 Europe Subscription-based Model Market by Country, 2024 - 2031, USD Million
TABLE 37 Europe Service-based Model Market by Country, 2020 - 2023, USD Million
TABLE 38 Europe Service-based Model Market by Country, 2024 - 2031, USD Million
TABLE 39 Europe Pay Per Use Model Market by Country, 2020 - 2023, USD Million
TABLE 40 Europe Pay Per Use Model Market by Country, 2024 - 2031, USD Million
TABLE 41 Europe Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 42 Europe Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 43 Europe Life Sciences Companies Market by Country, 2020 - 2023, USD Million
TABLE 44 Europe Life Sciences Companies Market by Country, 2024 - 2031, USD Million
TABLE 45 Europe Academic Research Institutions Market by Country, 2020 - 2023, USD Million
TABLE 46 Europe Academic Research Institutions Market by Country, 2024 - 2031, USD Million
TABLE 47 Europe Other End Use Market by Country, 2020 - 2023, USD Million
TABLE 48 Europe Other End Use Market by Country, 2024 - 2031, USD Million
TABLE 49 Europe Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 50 Europe Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 51 Europe Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 52 Europe Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 53 Europe Disease Modeling Market by Country, 2020 - 2023, USD Million
TABLE 54 Europe Disease Modeling Market by Country, 2024 - 2031, USD Million
TABLE 55 Europe Other Application Market by Country, 2020 - 2023, USD Million
TABLE 56 Europe Other Application Market by Country, 2024 - 2031, USD Million
TABLE 57 Europe Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 58 Europe Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 59 Europe Cloud-based Market by Country, 2020 - 2023, USD Million
TABLE 60 Europe Cloud-based Market by Country, 2024 - 2031, USD Million
TABLE 61 Europe On-premises Market by Country, 2020 - 2023, USD Million
TABLE 62 Europe On-premises Market by Country, 2024 - 2031, USD Million
TABLE 63 Europe Hybrid Model Market by Country, 2020 - 2023, USD Million
TABLE 64 Europe Hybrid Model Market by Country, 2024 - 2031, USD Million
TABLE 65 Europe Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 66 Europe Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 67 Europe Oncology Market by Country, 2020 - 2023, USD Million
TABLE 68 Europe Oncology Market by Country, 2024 - 2031, USD Million
TABLE 69 Europe Cardiovascular Disease Market by Country, 2020 - 2023, USD Million
TABLE 70 Europe Cardiovascular Disease Market by Country, 2024 - 2031, USD Million
TABLE 71 Europe Infectious Disease Market by Country, 2020 - 2023, USD Million
TABLE 72 Europe Infectious Disease Market by Country, 2024 - 2031, USD Million
TABLE 73 Europe Neurological Disorders Market by Country, 2020 - 2023, USD Million
TABLE 74 Europe Neurological Disorders Market by Country, 2024 - 2031, USD Million
TABLE 75 Europe Other Therapeutic Area Market by Country, 2020 - 2023, USD Million
TABLE 76 Europe Other Therapeutic Area Market by Country, 2024 - 2031, USD Million
TABLE 77 Europe Biosimulation Market by Country, 2020 - 2023, USD Million
TABLE 78 Europe Biosimulation Market by Country, 2024 - 2031, USD Million
TABLE 79 Germany Biosimulation Market, 2020 - 2023, USD Million
TABLE 80 Germany Biosimulation Market, 2024 - 2031, USD Million
TABLE 81 Germany Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 82 Germany Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 83 Germany Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 84 Germany Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 85 Germany Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 86 Germany Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 87 Germany Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 88 Germany Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 89 Germany Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 90 Germany Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 91 Germany Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 92 Germany Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 93 Germany Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 94 Germany Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 95 Germany Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 96 Germany Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 97 UK Biosimulation Market, 2020 - 2023, USD Million
TABLE 98 UK Biosimulation Market, 2024 - 2031, USD Million
TABLE 99 UK Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 100 UK Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 101 UK Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 102 UK Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 103 UK Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 104 UK Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 105 UK Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 106 UK Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 107 UK Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 108 UK Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 109 UK Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 110 UK Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 111 UK Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 112 UK Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 113 UK Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 114 UK Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 115 France Biosimulation Market, 2020 - 2023, USD Million
TABLE 116 France Biosimulation Market, 2024 - 2031, USD Million
TABLE 117 France Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 118 France Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 119 France Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 120 France Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 121 France Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 122 France Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 123 France Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 124 France Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 125 France Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 126 France Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 127 France Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 128 France Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 129 France Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 130 France Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 131 France Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 132 France Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 133 Russia Biosimulation Market, 2020 - 2023, USD Million
TABLE 134 Russia Biosimulation Market, 2024 - 2031, USD Million
TABLE 135 Russia Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 136 Russia Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 137 Russia Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 138 Russia Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 139 Russia Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 140 Russia Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 141 Russia Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 142 Russia Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 143 Russia Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 144 Russia Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 145 Russia Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 146 Russia Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 147 Russia Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 148 Russia Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 149 Russia Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 150 Russia Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 151 Spain Biosimulation Market, 2020 - 2023, USD Million
TABLE 152 Spain Biosimulation Market, 2024 - 2031, USD Million
TABLE 153 Spain Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 154 Spain Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 155 Spain Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 156 Spain Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 157 Spain Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 158 Spain Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 159 Spain Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 160 Spain Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 161 Spain Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 162 Spain Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 163 Spain Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 164 Spain Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 165 Spain Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 166 Spain Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 167 Spain Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 168 Spain Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 169 Italy Biosimulation Market, 2020 - 2023, USD Million
TABLE 170 Italy Biosimulation Market, 2024 - 2031, USD Million
TABLE 171 Italy Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 172 Italy Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 173 Italy Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 174 Italy Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 175 Italy Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 176 Italy Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 177 Italy Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 178 Italy Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 179 Italy Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 180 Italy Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 181 Italy Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 182 Italy Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 183 Italy Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 184 Italy Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 185 Italy Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 186 Italy Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 187 Rest of Europe Biosimulation Market, 2020 - 2023, USD Million
TABLE 188 Rest of Europe Biosimulation Market, 2024 - 2031, USD Million
TABLE 189 Rest of Europe Biosimulation Market by Product, 2020 - 2023, USD Million
TABLE 190 Rest of Europe Biosimulation Market by Product, 2024 - 2031, USD Million
TABLE 191 Rest of Europe Biosimulation Market by Software Type, 2020 - 2023, USD Million
TABLE 192 Rest of Europe Biosimulation Market by Software Type, 2024 - 2031, USD Million
TABLE 193 Rest of Europe Biosimulation Market by Services Type, 2020 - 2023, USD Million
TABLE 194 Rest of Europe Biosimulation Market by Services Type, 2024 - 2031, USD Million
TABLE 195 Rest of Europe Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
TABLE 196 Rest of Europe Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
TABLE 197 Rest of Europe Biosimulation Market by End Use, 2020 - 2023, USD Million
TABLE 198 Rest of Europe Biosimulation Market by End Use, 2024 - 2031, USD Million
TABLE 199 Rest of Europe Biosimulation Market by Application, 2020 - 2023, USD Million
TABLE 200 Rest of Europe Biosimulation Market by Application, 2024 - 2031, USD Million
TABLE 201 Rest of Europe Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
TABLE 202 Rest of Europe Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
TABLE 203 Rest of Europe Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
TABLE 204 Rest of Europe Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
TABLE 205 Key Information - Certara, Inc.
TABLE 206 Key Information - Dassault Systemes SE
TABLE 207 Key Information - Advanced Chemistry Development, Inc.
TABLE 208 Key Information - Genedata AG
TABLE 209 Key Information - Instem Group of Companies
TABLE 210 Key Information - Chemical Computing Group ULC
TABLE 211 Key Information - Simulations Plus, Inc.
TABLE 212 Key Information - Schrodinger, Inc.
TABLE 213 Key Information - PPD, Inc.
TABLE 214 Key Information - Physiomics Plc

Europe Biosimulation Market Size, Share & Trends Analysis Report By Product, By Pricing Model, By End Use, By Application, By Deployment Model (Cloud-based, On-premises, and Hybrid Model), By Therapeutic Area, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents